Lotus Eye Hospital and Institute: The Unaudited Financial Results for the quarter and half year ended September 30, 2026
Lotus Eye Hospital and Institute (LOTUSEYE) filed a disclosure titled "The Unaudited Financial Results for the quarter and half year ended September 30, 2026". The company is valued at about ₹222 crore.
What happened
Lotus Eye Hospital and Institute (LOTUSEYE) filed a disclosure with the exchanges on 11 November 2026 at 07:02 PM titled "The Unaudited Financial Results for the quarter and half year ended September 30, 2026".
From the filing: "LOTUSEYE: Lotus Eye Hospital and Institute Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter and half year ended September 30, 2026."
Company snapshot
Lotus Eye Hospital and Institute is a micro-cap company, with a market value of about ₹222 crore.
The stock last traded at ₹106.6, against a 52-week range of ₹97.59–₹147 (27.5% below the high).
Before this filing the shares had moved −12.2% over the month and −15.8% over three months. Average daily turnover over the last 20 sessions was about ₹0.31 crore.
Promoters held 40.14% at the end of Q1 FY27; 87.15% of promoter shares were pledged.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 14 | 0.5 | 0.26 |
| Q2 FY26 | 13 | 0.1 | 0.06 |
| Q3 FY26 | 14 | -0.3 | -0.13 |
| Q4 FY26 | 14 | -0.3 | -0.15 |
| Q1 FY27 | 17 | 0.6 | 0.3 |
What history shows
BCEIE's records show 6 previous results filings from the company since May 2026.
After those filings, the stock gained 1.4% on average the next trading day and was up 4.4% on average after five days (6 filings with price data).
Market-wide, 11,585 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 10 Aug 2026 | Results - Standalone Unaudited Financial Results For The Quarter… | +1.7% | +0.4% |
| 10 Aug 2026 | Board Meeting Outcome for Standalone Unaudited Financial Results For… | +1.7% | +0.4% |
| 5 Jun 2026 | Financial results for the period ended March 31, 2026 in machine… | +7.9% | +23.6% |
| 26 May 2026 | Board Meeting Outcome for Outcome Of The Board Meeting | −1.0% | +0.6% |
| 26 May 2026 | Standalone Audited Financial Results For Quarter And Year Ended… | −1.0% | +0.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 11 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.